Global Influenza Medication Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Influenza Medication market size was valued at USD 3153.3 million in 2023 and is forecast to a readjusted size of USD 4810.9 million by 2030 with a CAGR of 6.2% during review period.
Influenza medication includes antiviral drugs prescribed for the treatment of influenza. Influenza, also known as flu, is a respiratory disease caused by an influenza virus. It is a viral infectious disease that includes three major types: type A, type B, and type C. The common symptoms of the disorder are cold, cough, fever, and sore throat, which can be severe or mild. Seasonal outbreak of influenza primarily occurs in winter. Most people generally recover fully, but severe complications such as pneumonia can also develop. Initiation of antiviral treatment is recommended for hospitalized influenza patients. High growth of the global influenza medication market is due to unmet medical needs within the annual influenza epidemics along with strong R&D focus resulting in new and advanced treatments and drugs, and increasing demand due to government stockpiling.
In term of distribution channels, global influenza medications market is divided into hospitals, clinics, pharmacies and others. Incidence and prevalence of flu are gradually increasing across the globe. Of these, the pharmacies segment held dominance in 2017. Through the course of the forecast period, growth run witnessed by the segment is likely to remain steady due to the mushrooming pharmacy stores around the world. Besides this, the market is likely to witness lucrative prospects in the hospitals segment.
The Global Info Research report includes an overview of the development of the Influenza Medication industry chain, the market status of Hospitals (Zanamivir, Oseltamivir), Clinics (Zanamivir, Oseltamivir), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Influenza Medication.
Regionally, the report analyzes the Influenza Medication markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Influenza Medication market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Influenza Medication market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Influenza Medication industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Zanamivir, Oseltamivir).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Influenza Medication market.
Regional Analysis: The report involves examining the Influenza Medication market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Influenza Medication market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Influenza Medication:
Company Analysis: Report covers individual Influenza Medication manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Influenza Medication This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Clinics).
Technology Analysis: Report covers specific technologies relevant to Influenza Medication. It assesses the current state, advancements, and potential future developments in Influenza Medication areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Influenza Medication market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Influenza Medication market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Influenza Medication product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Influenza Medication, with price, sales, revenue and global market share of Influenza Medication from 2019 to 2024.
Chapter 3, the Influenza Medication competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Influenza Medication breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Influenza Medication market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Influenza Medication.
Chapter 14 and 15, to describe Influenza Medication sales channel, distributors, customers, research findings and conclusion.
Influenza medication includes antiviral drugs prescribed for the treatment of influenza. Influenza, also known as flu, is a respiratory disease caused by an influenza virus. It is a viral infectious disease that includes three major types: type A, type B, and type C. The common symptoms of the disorder are cold, cough, fever, and sore throat, which can be severe or mild. Seasonal outbreak of influenza primarily occurs in winter. Most people generally recover fully, but severe complications such as pneumonia can also develop. Initiation of antiviral treatment is recommended for hospitalized influenza patients. High growth of the global influenza medication market is due to unmet medical needs within the annual influenza epidemics along with strong R&D focus resulting in new and advanced treatments and drugs, and increasing demand due to government stockpiling.
In term of distribution channels, global influenza medications market is divided into hospitals, clinics, pharmacies and others. Incidence and prevalence of flu are gradually increasing across the globe. Of these, the pharmacies segment held dominance in 2017. Through the course of the forecast period, growth run witnessed by the segment is likely to remain steady due to the mushrooming pharmacy stores around the world. Besides this, the market is likely to witness lucrative prospects in the hospitals segment.
The Global Info Research report includes an overview of the development of the Influenza Medication industry chain, the market status of Hospitals (Zanamivir, Oseltamivir), Clinics (Zanamivir, Oseltamivir), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Influenza Medication.
Regionally, the report analyzes the Influenza Medication markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Influenza Medication market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Influenza Medication market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Influenza Medication industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Zanamivir, Oseltamivir).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Influenza Medication market.
Regional Analysis: The report involves examining the Influenza Medication market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Influenza Medication market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Influenza Medication:
Company Analysis: Report covers individual Influenza Medication manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Influenza Medication This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Clinics).
Technology Analysis: Report covers specific technologies relevant to Influenza Medication. It assesses the current state, advancements, and potential future developments in Influenza Medication areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Influenza Medication market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Influenza Medication market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Zanamivir
- Oseltamivir
- Peramivir
- Amantadine
- Rimantadine
- Inosine
- Others
- Hospitals
- Clinics
- Pharmacies
- Others
- Daiichi Sankyo Company
- GlaxoSmithKline
- Natco Pharma
- F. Hoffmann-La Roche
- Teva Pharmaceutical
- Sandoz International
- Sun Pharmaceutical Industries
- Mylan
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Influenza Medication product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Influenza Medication, with price, sales, revenue and global market share of Influenza Medication from 2019 to 2024.
Chapter 3, the Influenza Medication competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Influenza Medication breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Influenza Medication market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Influenza Medication.
Chapter 14 and 15, to describe Influenza Medication sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Influenza Medication
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Influenza Medication Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Zanamivir
1.3.3 Oseltamivir
1.3.4 Peramivir
1.3.5 Amantadine
1.3.6 Rimantadine
1.3.7 Inosine
1.3.8 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Influenza Medication Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Pharmacies
1.4.5 Others
1.5 Global Influenza Medication Market Size & Forecast
1.5.1 Global Influenza Medication Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Influenza Medication Sales Quantity (2019-2030)
1.5.3 Global Influenza Medication Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Daiichi Sankyo Company
2.1.1 Daiichi Sankyo Company Details
2.1.2 Daiichi Sankyo Company Major Business
2.1.3 Daiichi Sankyo Company Influenza Medication Product and Services
2.1.4 Daiichi Sankyo Company Influenza Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Daiichi Sankyo Company Recent Developments/Updates
2.2 GlaxoSmithKline
2.2.1 GlaxoSmithKline Details
2.2.2 GlaxoSmithKline Major Business
2.2.3 GlaxoSmithKline Influenza Medication Product and Services
2.2.4 GlaxoSmithKline Influenza Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 GlaxoSmithKline Recent Developments/Updates
2.3 Natco Pharma
2.3.1 Natco Pharma Details
2.3.2 Natco Pharma Major Business
2.3.3 Natco Pharma Influenza Medication Product and Services
2.3.4 Natco Pharma Influenza Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Natco Pharma Recent Developments/Updates
2.4 F. Hoffmann-La Roche
2.4.1 F. Hoffmann-La Roche Details
2.4.2 F. Hoffmann-La Roche Major Business
2.4.3 F. Hoffmann-La Roche Influenza Medication Product and Services
2.4.4 F. Hoffmann-La Roche Influenza Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 F. Hoffmann-La Roche Recent Developments/Updates
2.5 Teva Pharmaceutical
2.5.1 Teva Pharmaceutical Details
2.5.2 Teva Pharmaceutical Major Business
2.5.3 Teva Pharmaceutical Influenza Medication Product and Services
2.5.4 Teva Pharmaceutical Influenza Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Teva Pharmaceutical Recent Developments/Updates
2.6 Sandoz International
2.6.1 Sandoz International Details
2.6.2 Sandoz International Major Business
2.6.3 Sandoz International Influenza Medication Product and Services
2.6.4 Sandoz International Influenza Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Sandoz International Recent Developments/Updates
2.7 Sun Pharmaceutical Industries
2.7.1 Sun Pharmaceutical Industries Details
2.7.2 Sun Pharmaceutical Industries Major Business
2.7.3 Sun Pharmaceutical Industries Influenza Medication Product and Services
2.7.4 Sun Pharmaceutical Industries Influenza Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Sun Pharmaceutical Industries Recent Developments/Updates
2.8 Mylan
2.8.1 Mylan Details
2.8.2 Mylan Major Business
2.8.3 Mylan Influenza Medication Product and Services
2.8.4 Mylan Influenza Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Mylan Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: INFLUENZA MEDICATION BY MANUFACTURER
3.1 Global Influenza Medication Sales Quantity by Manufacturer (2019-2024)
3.2 Global Influenza Medication Revenue by Manufacturer (2019-2024)
3.3 Global Influenza Medication Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Influenza Medication by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Influenza Medication Manufacturer Market Share in 2023
3.4.2 Top 6 Influenza Medication Manufacturer Market Share in 2023
3.5 Influenza Medication Market: Overall Company Footprint Analysis
3.5.1 Influenza Medication Market: Region Footprint
3.5.2 Influenza Medication Market: Company Product Type Footprint
3.5.3 Influenza Medication Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Influenza Medication Market Size by Region
4.1.1 Global Influenza Medication Sales Quantity by Region (2019-2030)
4.1.2 Global Influenza Medication Consumption Value by Region (2019-2030)
4.1.3 Global Influenza Medication Average Price by Region (2019-2030)
4.2 North America Influenza Medication Consumption Value (2019-2030)
4.3 Europe Influenza Medication Consumption Value (2019-2030)
4.4 Asia-Pacific Influenza Medication Consumption Value (2019-2030)
4.5 South America Influenza Medication Consumption Value (2019-2030)
4.6 Middle East and Africa Influenza Medication Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Influenza Medication Sales Quantity by Type (2019-2030)
5.2 Global Influenza Medication Consumption Value by Type (2019-2030)
5.3 Global Influenza Medication Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Influenza Medication Sales Quantity by Application (2019-2030)
6.2 Global Influenza Medication Consumption Value by Application (2019-2030)
6.3 Global Influenza Medication Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Influenza Medication Sales Quantity by Type (2019-2030)
7.2 North America Influenza Medication Sales Quantity by Application (2019-2030)
7.3 North America Influenza Medication Market Size by Country
7.3.1 North America Influenza Medication Sales Quantity by Country (2019-2030)
7.3.2 North America Influenza Medication Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Influenza Medication Sales Quantity by Type (2019-2030)
8.2 Europe Influenza Medication Sales Quantity by Application (2019-2030)
8.3 Europe Influenza Medication Market Size by Country
8.3.1 Europe Influenza Medication Sales Quantity by Country (2019-2030)
8.3.2 Europe Influenza Medication Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Influenza Medication Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Influenza Medication Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Influenza Medication Market Size by Region
9.3.1 Asia-Pacific Influenza Medication Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Influenza Medication Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Influenza Medication Sales Quantity by Type (2019-2030)
10.2 South America Influenza Medication Sales Quantity by Application (2019-2030)
10.3 South America Influenza Medication Market Size by Country
10.3.1 South America Influenza Medication Sales Quantity by Country (2019-2030)
10.3.2 South America Influenza Medication Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Influenza Medication Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Influenza Medication Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Influenza Medication Market Size by Country
11.3.1 Middle East & Africa Influenza Medication Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Influenza Medication Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Influenza Medication Market Drivers
12.2 Influenza Medication Market Restraints
12.3 Influenza Medication Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Influenza Medication and Key Manufacturers
13.2 Manufacturing Costs Percentage of Influenza Medication
13.3 Influenza Medication Production Process
13.4 Influenza Medication Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Influenza Medication Typical Distributors
14.3 Influenza Medication Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Influenza Medication
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Influenza Medication Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Zanamivir
1.3.3 Oseltamivir
1.3.4 Peramivir
1.3.5 Amantadine
1.3.6 Rimantadine
1.3.7 Inosine
1.3.8 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Influenza Medication Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Pharmacies
1.4.5 Others
1.5 Global Influenza Medication Market Size & Forecast
1.5.1 Global Influenza Medication Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Influenza Medication Sales Quantity (2019-2030)
1.5.3 Global Influenza Medication Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Daiichi Sankyo Company
2.1.1 Daiichi Sankyo Company Details
2.1.2 Daiichi Sankyo Company Major Business
2.1.3 Daiichi Sankyo Company Influenza Medication Product and Services
2.1.4 Daiichi Sankyo Company Influenza Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Daiichi Sankyo Company Recent Developments/Updates
2.2 GlaxoSmithKline
2.2.1 GlaxoSmithKline Details
2.2.2 GlaxoSmithKline Major Business
2.2.3 GlaxoSmithKline Influenza Medication Product and Services
2.2.4 GlaxoSmithKline Influenza Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 GlaxoSmithKline Recent Developments/Updates
2.3 Natco Pharma
2.3.1 Natco Pharma Details
2.3.2 Natco Pharma Major Business
2.3.3 Natco Pharma Influenza Medication Product and Services
2.3.4 Natco Pharma Influenza Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Natco Pharma Recent Developments/Updates
2.4 F. Hoffmann-La Roche
2.4.1 F. Hoffmann-La Roche Details
2.4.2 F. Hoffmann-La Roche Major Business
2.4.3 F. Hoffmann-La Roche Influenza Medication Product and Services
2.4.4 F. Hoffmann-La Roche Influenza Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 F. Hoffmann-La Roche Recent Developments/Updates
2.5 Teva Pharmaceutical
2.5.1 Teva Pharmaceutical Details
2.5.2 Teva Pharmaceutical Major Business
2.5.3 Teva Pharmaceutical Influenza Medication Product and Services
2.5.4 Teva Pharmaceutical Influenza Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Teva Pharmaceutical Recent Developments/Updates
2.6 Sandoz International
2.6.1 Sandoz International Details
2.6.2 Sandoz International Major Business
2.6.3 Sandoz International Influenza Medication Product and Services
2.6.4 Sandoz International Influenza Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Sandoz International Recent Developments/Updates
2.7 Sun Pharmaceutical Industries
2.7.1 Sun Pharmaceutical Industries Details
2.7.2 Sun Pharmaceutical Industries Major Business
2.7.3 Sun Pharmaceutical Industries Influenza Medication Product and Services
2.7.4 Sun Pharmaceutical Industries Influenza Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Sun Pharmaceutical Industries Recent Developments/Updates
2.8 Mylan
2.8.1 Mylan Details
2.8.2 Mylan Major Business
2.8.3 Mylan Influenza Medication Product and Services
2.8.4 Mylan Influenza Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Mylan Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: INFLUENZA MEDICATION BY MANUFACTURER
3.1 Global Influenza Medication Sales Quantity by Manufacturer (2019-2024)
3.2 Global Influenza Medication Revenue by Manufacturer (2019-2024)
3.3 Global Influenza Medication Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Influenza Medication by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Influenza Medication Manufacturer Market Share in 2023
3.4.2 Top 6 Influenza Medication Manufacturer Market Share in 2023
3.5 Influenza Medication Market: Overall Company Footprint Analysis
3.5.1 Influenza Medication Market: Region Footprint
3.5.2 Influenza Medication Market: Company Product Type Footprint
3.5.3 Influenza Medication Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Influenza Medication Market Size by Region
4.1.1 Global Influenza Medication Sales Quantity by Region (2019-2030)
4.1.2 Global Influenza Medication Consumption Value by Region (2019-2030)
4.1.3 Global Influenza Medication Average Price by Region (2019-2030)
4.2 North America Influenza Medication Consumption Value (2019-2030)
4.3 Europe Influenza Medication Consumption Value (2019-2030)
4.4 Asia-Pacific Influenza Medication Consumption Value (2019-2030)
4.5 South America Influenza Medication Consumption Value (2019-2030)
4.6 Middle East and Africa Influenza Medication Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Influenza Medication Sales Quantity by Type (2019-2030)
5.2 Global Influenza Medication Consumption Value by Type (2019-2030)
5.3 Global Influenza Medication Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Influenza Medication Sales Quantity by Application (2019-2030)
6.2 Global Influenza Medication Consumption Value by Application (2019-2030)
6.3 Global Influenza Medication Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Influenza Medication Sales Quantity by Type (2019-2030)
7.2 North America Influenza Medication Sales Quantity by Application (2019-2030)
7.3 North America Influenza Medication Market Size by Country
7.3.1 North America Influenza Medication Sales Quantity by Country (2019-2030)
7.3.2 North America Influenza Medication Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Influenza Medication Sales Quantity by Type (2019-2030)
8.2 Europe Influenza Medication Sales Quantity by Application (2019-2030)
8.3 Europe Influenza Medication Market Size by Country
8.3.1 Europe Influenza Medication Sales Quantity by Country (2019-2030)
8.3.2 Europe Influenza Medication Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Influenza Medication Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Influenza Medication Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Influenza Medication Market Size by Region
9.3.1 Asia-Pacific Influenza Medication Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Influenza Medication Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Influenza Medication Sales Quantity by Type (2019-2030)
10.2 South America Influenza Medication Sales Quantity by Application (2019-2030)
10.3 South America Influenza Medication Market Size by Country
10.3.1 South America Influenza Medication Sales Quantity by Country (2019-2030)
10.3.2 South America Influenza Medication Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Influenza Medication Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Influenza Medication Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Influenza Medication Market Size by Country
11.3.1 Middle East & Africa Influenza Medication Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Influenza Medication Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Influenza Medication Market Drivers
12.2 Influenza Medication Market Restraints
12.3 Influenza Medication Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Influenza Medication and Key Manufacturers
13.2 Manufacturing Costs Percentage of Influenza Medication
13.3 Influenza Medication Production Process
13.4 Influenza Medication Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Influenza Medication Typical Distributors
14.3 Influenza Medication Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Influenza Medication Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Influenza Medication Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Daiichi Sankyo Company Basic Information, Manufacturing Base and Competitors
Table 4. Daiichi Sankyo Company Major Business
Table 5. Daiichi Sankyo Company Influenza Medication Product and Services
Table 6. Daiichi Sankyo Company Influenza Medication Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Daiichi Sankyo Company Recent Developments/Updates
Table 8. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 9. GlaxoSmithKline Major Business
Table 10. GlaxoSmithKline Influenza Medication Product and Services
Table 11. GlaxoSmithKline Influenza Medication Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. GlaxoSmithKline Recent Developments/Updates
Table 13. Natco Pharma Basic Information, Manufacturing Base and Competitors
Table 14. Natco Pharma Major Business
Table 15. Natco Pharma Influenza Medication Product and Services
Table 16. Natco Pharma Influenza Medication Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Natco Pharma Recent Developments/Updates
Table 18. F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 19. F. Hoffmann-La Roche Major Business
Table 20. F. Hoffmann-La Roche Influenza Medication Product and Services
Table 21. F. Hoffmann-La Roche Influenza Medication Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. F. Hoffmann-La Roche Recent Developments/Updates
Table 23. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Teva Pharmaceutical Major Business
Table 25. Teva Pharmaceutical Influenza Medication Product and Services
Table 26. Teva Pharmaceutical Influenza Medication Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Teva Pharmaceutical Recent Developments/Updates
Table 28. Sandoz International Basic Information, Manufacturing Base and Competitors
Table 29. Sandoz International Major Business
Table 30. Sandoz International Influenza Medication Product and Services
Table 31. Sandoz International Influenza Medication Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Sandoz International Recent Developments/Updates
Table 33. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 34. Sun Pharmaceutical Industries Major Business
Table 35. Sun Pharmaceutical Industries Influenza Medication Product and Services
Table 36. Sun Pharmaceutical Industries Influenza Medication Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Sun Pharmaceutical Industries Recent Developments/Updates
Table 38. Mylan Basic Information, Manufacturing Base and Competitors
Table 39. Mylan Major Business
Table 40. Mylan Influenza Medication Product and Services
Table 41. Mylan Influenza Medication Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Mylan Recent Developments/Updates
Table 43. Global Influenza Medication Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 44. Global Influenza Medication Revenue by Manufacturer (2019-2024) & (USD Million)
Table 45. Global Influenza Medication Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 46. Market Position of Manufacturers in Influenza Medication, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 47. Head Office and Influenza Medication Production Site of Key Manufacturer
Table 48. Influenza Medication Market: Company Product Type Footprint
Table 49. Influenza Medication Market: Company Product Application Footprint
Table 50. Influenza Medication New Market Entrants and Barriers to Market Entry
Table 51. Influenza Medication Mergers, Acquisition, Agreements, and Collaborations
Table 52. Global Influenza Medication Sales Quantity by Region (2019-2024) & (K Units)
Table 53. Global Influenza Medication Sales Quantity by Region (2025-2030) & (K Units)
Table 54. Global Influenza Medication Consumption Value by Region (2019-2024) & (USD Million)
Table 55. Global Influenza Medication Consumption Value by Region (2025-2030) & (USD Million)
Table 56. Global Influenza Medication Average Price by Region (2019-2024) & (USD/Unit)
Table 57. Global Influenza Medication Average Price by Region (2025-2030) & (USD/Unit)
Table 58. Global Influenza Medication Sales Quantity by Type (2019-2024) & (K Units)
Table 59. Global Influenza Medication Sales Quantity by Type (2025-2030) & (K Units)
Table 60. Global Influenza Medication Consumption Value by Type (2019-2024) & (USD Million)
Table 61. Global Influenza Medication Consumption Value by Type (2025-2030) & (USD Million)
Table 62. Global Influenza Medication Average Price by Type (2019-2024) & (USD/Unit)
Table 63. Global Influenza Medication Average Price by Type (2025-2030) & (USD/Unit)
Table 64. Global Influenza Medication Sales Quantity by Application (2019-2024) & (K Units)
Table 65. Global Influenza Medication Sales Quantity by Application (2025-2030) & (K Units)
Table 66. Global Influenza Medication Consumption Value by Application (2019-2024) & (USD Million)
Table 67. Global Influenza Medication Consumption Value by Application (2025-2030) & (USD Million)
Table 68. Global Influenza Medication Average Price by Application (2019-2024) & (USD/Unit)
Table 69. Global Influenza Medication Average Price by Application (2025-2030) & (USD/Unit)
Table 70. North America Influenza Medication Sales Quantity by Type (2019-2024) & (K Units)
Table 71. North America Influenza Medication Sales Quantity by Type (2025-2030) & (K Units)
Table 72. North America Influenza Medication Sales Quantity by Application (2019-2024) & (K Units)
Table 73. North America Influenza Medication Sales Quantity by Application (2025-2030) & (K Units)
Table 74. North America Influenza Medication Sales Quantity by Country (2019-2024) & (K Units)
Table 75. North America Influenza Medication Sales Quantity by Country (2025-2030) & (K Units)
Table 76. North America Influenza Medication Consumption Value by Country (2019-2024) & (USD Million)
Table 77. North America Influenza Medication Consumption Value by Country (2025-2030) & (USD Million)
Table 78. Europe Influenza Medication Sales Quantity by Type (2019-2024) & (K Units)
Table 79. Europe Influenza Medication Sales Quantity by Type (2025-2030) & (K Units)
Table 80. Europe Influenza Medication Sales Quantity by Application (2019-2024) & (K Units)
Table 81. Europe Influenza Medication Sales Quantity by Application (2025-2030) & (K Units)
Table 82. Europe Influenza Medication Sales Quantity by Country (2019-2024) & (K Units)
Table 83. Europe Influenza Medication Sales Quantity by Country (2025-2030) & (K Units)
Table 84. Europe Influenza Medication Consumption Value by Country (2019-2024) & (USD Million)
Table 85. Europe Influenza Medication Consumption Value by Country (2025-2030) & (USD Million)
Table 86. Asia-Pacific Influenza Medication Sales Quantity by Type (2019-2024) & (K Units)
Table 87. Asia-Pacific Influenza Medication Sales Quantity by Type (2025-2030) & (K Units)
Table 88. Asia-Pacific Influenza Medication Sales Quantity by Application (2019-2024) & (K Units)
Table 89. Asia-Pacific Influenza Medication Sales Quantity by Application (2025-2030) & (K Units)
Table 90. Asia-Pacific Influenza Medication Sales Quantity by Region (2019-2024) & (K Units)
Table 91. Asia-Pacific Influenza Medication Sales Quantity by Region (2025-2030) & (K Units)
Table 92. Asia-Pacific Influenza Medication Consumption Value by Region (2019-2024) & (USD Million)
Table 93. Asia-Pacific Influenza Medication Consumption Value by Region (2025-2030) & (USD Million)
Table 94. South America Influenza Medication Sales Quantity by Type (2019-2024) & (K Units)
Table 95. South America Influenza Medication Sales Quantity by Type (2025-2030) & (K Units)
Table 96. South America Influenza Medication Sales Quantity by Application (2019-2024) & (K Units)
Table 97. South America Influenza Medication Sales Quantity by Application (2025-2030) & (K Units)
Table 98. South America Influenza Medication Sales Quantity by Country (2019-2024) & (K Units)
Table 99. South America Influenza Medication Sales Quantity by Country (2025-2030) & (K Units)
Table 100. South America Influenza Medication Consumption Value by Country (2019-2024) & (USD Million)
Table 101. South America Influenza Medication Consumption Value by Country (2025-2030) & (USD Million)
Table 102. Middle East & Africa Influenza Medication Sales Quantity by Type (2019-2024) & (K Units)
Table 103. Middle East & Africa Influenza Medication Sales Quantity by Type (2025-2030) & (K Units)
Table 104. Middle East & Africa Influenza Medication Sales Quantity by Application (2019-2024) & (K Units)
Table 105. Middle East & Africa Influenza Medication Sales Quantity by Application (2025-2030) & (K Units)
Table 106. Middle East & Africa Influenza Medication Sales Quantity by Region (2019-2024) & (K Units)
Table 107. Middle East & Africa Influenza Medication Sales Quantity by Region (2025-2030) & (K Units)
Table 108. Middle East & Africa Influenza Medication Consumption Value by Region (2019-2024) & (USD Million)
Table 109. Middle East & Africa Influenza Medication Consumption Value by Region (2025-2030) & (USD Million)
Table 110. Influenza Medication Raw Material
Table 111. Key Manufacturers of Influenza Medication Raw Materials
Table 112. Influenza Medication Typical Distributors
Table 113. Influenza Medication Typical Customers
Table 1. Global Influenza Medication Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Influenza Medication Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Daiichi Sankyo Company Basic Information, Manufacturing Base and Competitors
Table 4. Daiichi Sankyo Company Major Business
Table 5. Daiichi Sankyo Company Influenza Medication Product and Services
Table 6. Daiichi Sankyo Company Influenza Medication Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Daiichi Sankyo Company Recent Developments/Updates
Table 8. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 9. GlaxoSmithKline Major Business
Table 10. GlaxoSmithKline Influenza Medication Product and Services
Table 11. GlaxoSmithKline Influenza Medication Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. GlaxoSmithKline Recent Developments/Updates
Table 13. Natco Pharma Basic Information, Manufacturing Base and Competitors
Table 14. Natco Pharma Major Business
Table 15. Natco Pharma Influenza Medication Product and Services
Table 16. Natco Pharma Influenza Medication Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Natco Pharma Recent Developments/Updates
Table 18. F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 19. F. Hoffmann-La Roche Major Business
Table 20. F. Hoffmann-La Roche Influenza Medication Product and Services
Table 21. F. Hoffmann-La Roche Influenza Medication Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. F. Hoffmann-La Roche Recent Developments/Updates
Table 23. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Teva Pharmaceutical Major Business
Table 25. Teva Pharmaceutical Influenza Medication Product and Services
Table 26. Teva Pharmaceutical Influenza Medication Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Teva Pharmaceutical Recent Developments/Updates
Table 28. Sandoz International Basic Information, Manufacturing Base and Competitors
Table 29. Sandoz International Major Business
Table 30. Sandoz International Influenza Medication Product and Services
Table 31. Sandoz International Influenza Medication Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Sandoz International Recent Developments/Updates
Table 33. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 34. Sun Pharmaceutical Industries Major Business
Table 35. Sun Pharmaceutical Industries Influenza Medication Product and Services
Table 36. Sun Pharmaceutical Industries Influenza Medication Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Sun Pharmaceutical Industries Recent Developments/Updates
Table 38. Mylan Basic Information, Manufacturing Base and Competitors
Table 39. Mylan Major Business
Table 40. Mylan Influenza Medication Product and Services
Table 41. Mylan Influenza Medication Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Mylan Recent Developments/Updates
Table 43. Global Influenza Medication Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 44. Global Influenza Medication Revenue by Manufacturer (2019-2024) & (USD Million)
Table 45. Global Influenza Medication Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 46. Market Position of Manufacturers in Influenza Medication, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 47. Head Office and Influenza Medication Production Site of Key Manufacturer
Table 48. Influenza Medication Market: Company Product Type Footprint
Table 49. Influenza Medication Market: Company Product Application Footprint
Table 50. Influenza Medication New Market Entrants and Barriers to Market Entry
Table 51. Influenza Medication Mergers, Acquisition, Agreements, and Collaborations
Table 52. Global Influenza Medication Sales Quantity by Region (2019-2024) & (K Units)
Table 53. Global Influenza Medication Sales Quantity by Region (2025-2030) & (K Units)
Table 54. Global Influenza Medication Consumption Value by Region (2019-2024) & (USD Million)
Table 55. Global Influenza Medication Consumption Value by Region (2025-2030) & (USD Million)
Table 56. Global Influenza Medication Average Price by Region (2019-2024) & (USD/Unit)
Table 57. Global Influenza Medication Average Price by Region (2025-2030) & (USD/Unit)
Table 58. Global Influenza Medication Sales Quantity by Type (2019-2024) & (K Units)
Table 59. Global Influenza Medication Sales Quantity by Type (2025-2030) & (K Units)
Table 60. Global Influenza Medication Consumption Value by Type (2019-2024) & (USD Million)
Table 61. Global Influenza Medication Consumption Value by Type (2025-2030) & (USD Million)
Table 62. Global Influenza Medication Average Price by Type (2019-2024) & (USD/Unit)
Table 63. Global Influenza Medication Average Price by Type (2025-2030) & (USD/Unit)
Table 64. Global Influenza Medication Sales Quantity by Application (2019-2024) & (K Units)
Table 65. Global Influenza Medication Sales Quantity by Application (2025-2030) & (K Units)
Table 66. Global Influenza Medication Consumption Value by Application (2019-2024) & (USD Million)
Table 67. Global Influenza Medication Consumption Value by Application (2025-2030) & (USD Million)
Table 68. Global Influenza Medication Average Price by Application (2019-2024) & (USD/Unit)
Table 69. Global Influenza Medication Average Price by Application (2025-2030) & (USD/Unit)
Table 70. North America Influenza Medication Sales Quantity by Type (2019-2024) & (K Units)
Table 71. North America Influenza Medication Sales Quantity by Type (2025-2030) & (K Units)
Table 72. North America Influenza Medication Sales Quantity by Application (2019-2024) & (K Units)
Table 73. North America Influenza Medication Sales Quantity by Application (2025-2030) & (K Units)
Table 74. North America Influenza Medication Sales Quantity by Country (2019-2024) & (K Units)
Table 75. North America Influenza Medication Sales Quantity by Country (2025-2030) & (K Units)
Table 76. North America Influenza Medication Consumption Value by Country (2019-2024) & (USD Million)
Table 77. North America Influenza Medication Consumption Value by Country (2025-2030) & (USD Million)
Table 78. Europe Influenza Medication Sales Quantity by Type (2019-2024) & (K Units)
Table 79. Europe Influenza Medication Sales Quantity by Type (2025-2030) & (K Units)
Table 80. Europe Influenza Medication Sales Quantity by Application (2019-2024) & (K Units)
Table 81. Europe Influenza Medication Sales Quantity by Application (2025-2030) & (K Units)
Table 82. Europe Influenza Medication Sales Quantity by Country (2019-2024) & (K Units)
Table 83. Europe Influenza Medication Sales Quantity by Country (2025-2030) & (K Units)
Table 84. Europe Influenza Medication Consumption Value by Country (2019-2024) & (USD Million)
Table 85. Europe Influenza Medication Consumption Value by Country (2025-2030) & (USD Million)
Table 86. Asia-Pacific Influenza Medication Sales Quantity by Type (2019-2024) & (K Units)
Table 87. Asia-Pacific Influenza Medication Sales Quantity by Type (2025-2030) & (K Units)
Table 88. Asia-Pacific Influenza Medication Sales Quantity by Application (2019-2024) & (K Units)
Table 89. Asia-Pacific Influenza Medication Sales Quantity by Application (2025-2030) & (K Units)
Table 90. Asia-Pacific Influenza Medication Sales Quantity by Region (2019-2024) & (K Units)
Table 91. Asia-Pacific Influenza Medication Sales Quantity by Region (2025-2030) & (K Units)
Table 92. Asia-Pacific Influenza Medication Consumption Value by Region (2019-2024) & (USD Million)
Table 93. Asia-Pacific Influenza Medication Consumption Value by Region (2025-2030) & (USD Million)
Table 94. South America Influenza Medication Sales Quantity by Type (2019-2024) & (K Units)
Table 95. South America Influenza Medication Sales Quantity by Type (2025-2030) & (K Units)
Table 96. South America Influenza Medication Sales Quantity by Application (2019-2024) & (K Units)
Table 97. South America Influenza Medication Sales Quantity by Application (2025-2030) & (K Units)
Table 98. South America Influenza Medication Sales Quantity by Country (2019-2024) & (K Units)
Table 99. South America Influenza Medication Sales Quantity by Country (2025-2030) & (K Units)
Table 100. South America Influenza Medication Consumption Value by Country (2019-2024) & (USD Million)
Table 101. South America Influenza Medication Consumption Value by Country (2025-2030) & (USD Million)
Table 102. Middle East & Africa Influenza Medication Sales Quantity by Type (2019-2024) & (K Units)
Table 103. Middle East & Africa Influenza Medication Sales Quantity by Type (2025-2030) & (K Units)
Table 104. Middle East & Africa Influenza Medication Sales Quantity by Application (2019-2024) & (K Units)
Table 105. Middle East & Africa Influenza Medication Sales Quantity by Application (2025-2030) & (K Units)
Table 106. Middle East & Africa Influenza Medication Sales Quantity by Region (2019-2024) & (K Units)
Table 107. Middle East & Africa Influenza Medication Sales Quantity by Region (2025-2030) & (K Units)
Table 108. Middle East & Africa Influenza Medication Consumption Value by Region (2019-2024) & (USD Million)
Table 109. Middle East & Africa Influenza Medication Consumption Value by Region (2025-2030) & (USD Million)
Table 110. Influenza Medication Raw Material
Table 111. Key Manufacturers of Influenza Medication Raw Materials
Table 112. Influenza Medication Typical Distributors
Table 113. Influenza Medication Typical Customers
LIST OF FIGURES
Figure 1. Influenza Medication Picture
Figure 2. Global Influenza Medication Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Influenza Medication Consumption Value Market Share by Type in 2023
Figure 4. Zanamivir Examples
Figure 5. Oseltamivir Examples
Figure 6. Peramivir Examples
Figure 7. Amantadine Examples
Figure 8. Rimantadine Examples
Figure 9. Inosine Examples
Figure 10. Others Examples
Figure 11. Global Influenza Medication Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 12. Global Influenza Medication Consumption Value Market Share by Application in 2023
Figure 13. Hospitals Examples
Figure 14. Clinics Examples
Figure 15. Pharmacies Examples
Figure 16. Others Examples
Figure 17. Global Influenza Medication Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 18. Global Influenza Medication Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 19. Global Influenza Medication Sales Quantity (2019-2030) & (K Units)
Figure 20. Global Influenza Medication Average Price (2019-2030) & (USD/Unit)
Figure 21. Global Influenza Medication Sales Quantity Market Share by Manufacturer in 2023
Figure 22. Global Influenza Medication Consumption Value Market Share by Manufacturer in 2023
Figure 23. Producer Shipments of Influenza Medication by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 24. Top 3 Influenza Medication Manufacturer (Consumption Value) Market Share in 2023
Figure 25. Top 6 Influenza Medication Manufacturer (Consumption Value) Market Share in 2023
Figure 26. Global Influenza Medication Sales Quantity Market Share by Region (2019-2030)
Figure 27. Global Influenza Medication Consumption Value Market Share by Region (2019-2030)
Figure 28. North America Influenza Medication Consumption Value (2019-2030) & (USD Million)
Figure 29. Europe Influenza Medication Consumption Value (2019-2030) & (USD Million)
Figure 30. Asia-Pacific Influenza Medication Consumption Value (2019-2030) & (USD Million)
Figure 31. South America Influenza Medication Consumption Value (2019-2030) & (USD Million)
Figure 32. Middle East & Africa Influenza Medication Consumption Value (2019-2030) & (USD Million)
Figure 33. Global Influenza Medication Sales Quantity Market Share by Type (2019-2030)
Figure 34. Global Influenza Medication Consumption Value Market Share by Type (2019-2030)
Figure 35. Global Influenza Medication Average Price by Type (2019-2030) & (USD/Unit)
Figure 36. Global Influenza Medication Sales Quantity Market Share by Application (2019-2030)
Figure 37. Global Influenza Medication Consumption Value Market Share by Application (2019-2030)
Figure 38. Global Influenza Medication Average Price by Application (2019-2030) & (USD/Unit)
Figure 39. North America Influenza Medication Sales Quantity Market Share by Type (2019-2030)
Figure 40. North America Influenza Medication Sales Quantity Market Share by Application (2019-2030)
Figure 41. North America Influenza Medication Sales Quantity Market Share by Country (2019-2030)
Figure 42. North America Influenza Medication Consumption Value Market Share by Country (2019-2030)
Figure 43. United States Influenza Medication Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. Canada Influenza Medication Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. Mexico Influenza Medication Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Europe Influenza Medication Sales Quantity Market Share by Type (2019-2030)
Figure 47. Europe Influenza Medication Sales Quantity Market Share by Application (2019-2030)
Figure 48. Europe Influenza Medication Sales Quantity Market Share by Country (2019-2030)
Figure 49. Europe Influenza Medication Consumption Value Market Share by Country (2019-2030)
Figure 50. Germany Influenza Medication Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. France Influenza Medication Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. United Kingdom Influenza Medication Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Russia Influenza Medication Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Italy Influenza Medication Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Asia-Pacific Influenza Medication Sales Quantity Market Share by Type (2019-2030)
Figure 56. Asia-Pacific Influenza Medication Sales Quantity Market Share by Application (2019-2030)
Figure 57. Asia-Pacific Influenza Medication Sales Quantity Market Share by Region (2019-2030)
Figure 58. Asia-Pacific Influenza Medication Consumption Value Market Share by Region (2019-2030)
Figure 59. China Influenza Medication Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Japan Influenza Medication Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Korea Influenza Medication Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. India Influenza Medication Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Southeast Asia Influenza Medication Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Australia Influenza Medication Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. South America Influenza Medication Sales Quantity Market Share by Type (2019-2030)
Figure 66. South America Influenza Medication Sales Quantity Market Share by Application (2019-2030)
Figure 67. South America Influenza Medication Sales Quantity Market Share by Country (2019-2030)
Figure 68. South America Influenza Medication Consumption Value Market Share by Country (2019-2030)
Figure 69. Brazil Influenza Medication Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Argentina Influenza Medication Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Middle East & Africa Influenza Medication Sales Quantity Market Share by Type (2019-2030)
Figure 72. Middle East & Africa Influenza Medication Sales Quantity Market Share by Application (2019-2030)
Figure 73. Middle East & Africa Influenza Medication Sales Quantity Market Share by Region (2019-2030)
Figure 74. Middle East & Africa Influenza Medication Consumption Value Market Share by Region (2019-2030)
Figure 75. Turkey Influenza Medication Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. Egypt Influenza Medication Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 77. Saudi Arabia Influenza Medication Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 78. South Africa Influenza Medication Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 79. Influenza Medication Market Drivers
Figure 80. Influenza Medication Market Restraints
Figure 81. Influenza Medication Market Trends
Figure 82. Porters Five Forces Analysis
Figure 83. Manufacturing Cost Structure Analysis of Influenza Medication in 2023
Figure 84. Manufacturing Process Analysis of Influenza Medication
Figure 85. Influenza Medication Industrial Chain
Figure 86. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 87. Direct Channel Pros & Cons
Figure 88. Indirect Channel Pros & Cons
Figure 89. Methodology
Figure 90. Research Process and Data Source
Figure 1. Influenza Medication Picture
Figure 2. Global Influenza Medication Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Influenza Medication Consumption Value Market Share by Type in 2023
Figure 4. Zanamivir Examples
Figure 5. Oseltamivir Examples
Figure 6. Peramivir Examples
Figure 7. Amantadine Examples
Figure 8. Rimantadine Examples
Figure 9. Inosine Examples
Figure 10. Others Examples
Figure 11. Global Influenza Medication Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 12. Global Influenza Medication Consumption Value Market Share by Application in 2023
Figure 13. Hospitals Examples
Figure 14. Clinics Examples
Figure 15. Pharmacies Examples
Figure 16. Others Examples
Figure 17. Global Influenza Medication Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 18. Global Influenza Medication Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 19. Global Influenza Medication Sales Quantity (2019-2030) & (K Units)
Figure 20. Global Influenza Medication Average Price (2019-2030) & (USD/Unit)
Figure 21. Global Influenza Medication Sales Quantity Market Share by Manufacturer in 2023
Figure 22. Global Influenza Medication Consumption Value Market Share by Manufacturer in 2023
Figure 23. Producer Shipments of Influenza Medication by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 24. Top 3 Influenza Medication Manufacturer (Consumption Value) Market Share in 2023
Figure 25. Top 6 Influenza Medication Manufacturer (Consumption Value) Market Share in 2023
Figure 26. Global Influenza Medication Sales Quantity Market Share by Region (2019-2030)
Figure 27. Global Influenza Medication Consumption Value Market Share by Region (2019-2030)
Figure 28. North America Influenza Medication Consumption Value (2019-2030) & (USD Million)
Figure 29. Europe Influenza Medication Consumption Value (2019-2030) & (USD Million)
Figure 30. Asia-Pacific Influenza Medication Consumption Value (2019-2030) & (USD Million)
Figure 31. South America Influenza Medication Consumption Value (2019-2030) & (USD Million)
Figure 32. Middle East & Africa Influenza Medication Consumption Value (2019-2030) & (USD Million)
Figure 33. Global Influenza Medication Sales Quantity Market Share by Type (2019-2030)
Figure 34. Global Influenza Medication Consumption Value Market Share by Type (2019-2030)
Figure 35. Global Influenza Medication Average Price by Type (2019-2030) & (USD/Unit)
Figure 36. Global Influenza Medication Sales Quantity Market Share by Application (2019-2030)
Figure 37. Global Influenza Medication Consumption Value Market Share by Application (2019-2030)
Figure 38. Global Influenza Medication Average Price by Application (2019-2030) & (USD/Unit)
Figure 39. North America Influenza Medication Sales Quantity Market Share by Type (2019-2030)
Figure 40. North America Influenza Medication Sales Quantity Market Share by Application (2019-2030)
Figure 41. North America Influenza Medication Sales Quantity Market Share by Country (2019-2030)
Figure 42. North America Influenza Medication Consumption Value Market Share by Country (2019-2030)
Figure 43. United States Influenza Medication Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. Canada Influenza Medication Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. Mexico Influenza Medication Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Europe Influenza Medication Sales Quantity Market Share by Type (2019-2030)
Figure 47. Europe Influenza Medication Sales Quantity Market Share by Application (2019-2030)
Figure 48. Europe Influenza Medication Sales Quantity Market Share by Country (2019-2030)
Figure 49. Europe Influenza Medication Consumption Value Market Share by Country (2019-2030)
Figure 50. Germany Influenza Medication Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. France Influenza Medication Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. United Kingdom Influenza Medication Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Russia Influenza Medication Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Italy Influenza Medication Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Asia-Pacific Influenza Medication Sales Quantity Market Share by Type (2019-2030)
Figure 56. Asia-Pacific Influenza Medication Sales Quantity Market Share by Application (2019-2030)
Figure 57. Asia-Pacific Influenza Medication Sales Quantity Market Share by Region (2019-2030)
Figure 58. Asia-Pacific Influenza Medication Consumption Value Market Share by Region (2019-2030)
Figure 59. China Influenza Medication Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Japan Influenza Medication Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Korea Influenza Medication Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. India Influenza Medication Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Southeast Asia Influenza Medication Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Australia Influenza Medication Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. South America Influenza Medication Sales Quantity Market Share by Type (2019-2030)
Figure 66. South America Influenza Medication Sales Quantity Market Share by Application (2019-2030)
Figure 67. South America Influenza Medication Sales Quantity Market Share by Country (2019-2030)
Figure 68. South America Influenza Medication Consumption Value Market Share by Country (2019-2030)
Figure 69. Brazil Influenza Medication Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Argentina Influenza Medication Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Middle East & Africa Influenza Medication Sales Quantity Market Share by Type (2019-2030)
Figure 72. Middle East & Africa Influenza Medication Sales Quantity Market Share by Application (2019-2030)
Figure 73. Middle East & Africa Influenza Medication Sales Quantity Market Share by Region (2019-2030)
Figure 74. Middle East & Africa Influenza Medication Consumption Value Market Share by Region (2019-2030)
Figure 75. Turkey Influenza Medication Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. Egypt Influenza Medication Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 77. Saudi Arabia Influenza Medication Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 78. South Africa Influenza Medication Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 79. Influenza Medication Market Drivers
Figure 80. Influenza Medication Market Restraints
Figure 81. Influenza Medication Market Trends
Figure 82. Porters Five Forces Analysis
Figure 83. Manufacturing Cost Structure Analysis of Influenza Medication in 2023
Figure 84. Manufacturing Process Analysis of Influenza Medication
Figure 85. Influenza Medication Industrial Chain
Figure 86. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 87. Direct Channel Pros & Cons
Figure 88. Indirect Channel Pros & Cons
Figure 89. Methodology
Figure 90. Research Process and Data Source
